Add a bookmark to get started

Default image

Juliana Marcondes

Senior Associate

Juliana Marcondes represents medical technology manufacturers, biotechs, diagnostics manufacturers and distributors of medical products in the pre-litigation consulting services space. She works with cross-disciplinary teams to provide legal services across the life sciences, healthcare and cannabis landscapes.

Juliana is experienced in product liability and product safety. She has defended leading corporations against class action disputes and related regulatory proceedings while anticipating emerging threats, developing effective strategies that respond to the nuances of the matter at hand and remaining mindful of overall business objectives.

DLA Piper and Campos Mello Advogados (CMA) are separate and independent law firms, which work in cooperation with one another. Partners of DLA Piper are not partners of CMA; and CMA partners are not partners of DLA Piper. 
  • Portuguese
  • English
  • Universidade das Faculdades Metropolitanas Unidas, B.A., 2002

Pro Bono

Juliana assisted the International Rehabilitation Centre for Torture (IRCT) in research on the status of remote legal and medico-legal examinations. The research will support the development of guidelines for medico-legal examinations of torture victims.


  • Co-Author, "Cannabis-based products: takeaways & future policy changes"
  • Co-Author, "The new regulatory scheme for Software as a Medical Device approved by Anvisa"
  • Co-Author, "The importance behind the recent scientific advances in reversing ageing in human egg cells"
  • Co-Author, "Telehealth in Brazil: the Bill goes to the Senate and the Federal Court of Medicine regulates the practice of telemedicine"
  • Co-Author, "Digital Health Transformation: the new Brazilian law on digital drugs leaflets"
  • Co-Author, "The Federal Council of Nursing regulates the exercise of Telenursing"
  • Co-Author, "The Brazilian Minister of Health approves the Ordinance regulating telehealth in Brazil"
  • Co-Author, "The Brazilian Federal Council of Pharmacy regulates telepharmacy"